Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Draths was a U.S. industrial biotechnology and renewable chemicals company that developed biobased manufacturing processes for commodity and specialty chemical intermediates. Its platform combined chemistry, biology, genetic engineering, fermentation, and green chemistry to make petroleum-derived materials from renewable feedstocks. The company focused on intermediates used in nylons, plastics, paints, resins, polyesters, and related materials rather than human therapeutics. Draths was founded by John Frost and Karen Frost in Michigan and was later acquired by Amyris in 2011. It appears to have ceased operating as an independent company following the acquisition.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Draths.